10 April 2020

Sanofi offers 100 mln doses of hydroxychloroquine in COVID-19 fight - France 24


French pharmaceutical giant Sanofi said Friday it would offer 100 million doses of hydroxychloroquine, a treatment for rheumatoid arthritis and lupus, to governments worldwide if studies show it can safely to be used to treat COVID-19 patients. Both hydroxychloroquine, which Sanofi sells under the brand name Plaquenil, and the related compound chloroquine, an anti-malarial drug, are being studied worldwide as potential weapons in the coronavirus fight. But proposals to put them to use [...]